Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The skeletal effects of the tyrosine kinase inhibitor nilotinib.
Bone. 2011 Aug;49(2):281-9. doi: 10.1016/j.bone.2011.04.014. Epub 2011 Apr 29.
Bone. 2011.
PMID: 21550432
Clinical Trial.
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S, Naot D, Callon K, Porteous F, Horne A, Wattie D, Watson M, Cornish J, Browett P, Grey A.
O'Sullivan S, et al. Among authors: porteous f.
J Bone Miner Res. 2007 Nov;22(11):1679-89. doi: 10.1359/jbmr.070719.
J Bone Miner Res. 2007.
PMID: 17663639
Free article.
Item in Clipboard
Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib.
O'Sullivan S, Horne A, Wattie D, Porteous F, Callon K, Gamble G, Ebeling P, Browett P, Grey A.
O'Sullivan S, et al. Among authors: porteous f.
J Clin Endocrinol Metab. 2009 Apr;94(4):1131-6. doi: 10.1210/jc.2008-2324. Epub 2009 Jan 27.
J Clin Endocrinol Metab. 2009.
PMID: 19174494
Item in Clipboard
Bone metabolism during long-term treatment with imatinib.
O'Sullivan S, Horne A, Wattie D, Porteous F, Gamble G, Browett P, Grey A.
O'Sullivan S, et al. Among authors: porteous f.
Leuk Lymphoma. 2013 Aug;54(8):1783-5. doi: 10.3109/10428194.2012.760734. Epub 2013 Jan 24.
Leuk Lymphoma. 2013.
PMID: 23278638
No abstract available.
Item in Clipboard
Use of a lux-marked rhizobacterium as a biosensor to assess changes in rhizosphere C flow due to pollutant stress.
Porteous F, Killham K, Meharg A.
Porteous F, et al.
Chemosphere. 2000 Nov;41(10):1549-54. doi: 10.1016/s0045-6535(00)00072-2.
Chemosphere. 2000.
PMID: 11057680
Item in Clipboard
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group.
Gallus A, Cade J, Ockelford P, Hepburn S, Maas M, Magnani H, Bucknall T, Stevens J, Porteous F.
Gallus A, et al. Among authors: porteous f.
Thromb Haemost. 1993 Oct 18;70(4):562-7.
Thromb Haemost. 1993.
PMID: 7509509
Clinical Trial.
Item in Clipboard
Cite
Cite